Arachidonic acid (ARA) market is expected to grow over the forecast period owing to the increasing demand for animal feeds, human medicines, and chemical compounds. Arachidonic acid is a long chain fatty acid, which along with docosahexaenoic acid (DHA), helps in the development of infants’ brain. The increasing levels of child care awareness and baby care products are the primary growth drivers for this industry.
Arachidonic acid is one of the essential acids in the Omega-6 group. The reason for it, being an essential acid, is that it is stored in the cell membranes and sends signals of adaptive changes in the events of muscle damages. The lack of natural arachidonic acid in the body requires a separate intake of it in the form of tablets, syrups, or injections. Increasing demand for the product to heal critical physical injuries is likely to increase its demand over the next eight years. With the growing outdoor sporting activities including car racing, marathons, Olympics, and FIFA, the possibility of physical injuries is expected to increase, which in turn, is likely to bring about a positive change in this sector. Also, the increment in the road accidents and hence the growing number of cases of muscle damages in the people is expected to affect the demand optimistically.
The DSM Food Specialties B.V. (DSM) and Martek Biosciences Corp (MATK) collaborated with each other and entered into an agreement between the two companies that involve the production and supply of the chemical (ARA). Under the terms and conditions of this agreement, the companies are licensed to make use of the intellectual properties of each other related to ARA and perform research and development to study about the expansion of the industry. Such collaborations are expected to impact the growth on a positive note. DSM will probably expand its production facilities to satisfy the present and anticipated growing demand for ARA in the market. The making of this acid has several intellectual property rights issues attached to it, which might hamper the growth of the market as the investors and venture capitalists refrain themselves to step into such things. The companies grant rights for the intellectual properties to each other and work together for better business opportunities to overcome this problem.
The market is segmented based on the end use application of arachidonic acid produced such as non-human use and human use. The non-human usable acid which includes animal feed and accounts for the major share of the market and is expected to take a leap forward over the forecast period, owing to the increasing animal care awareness in the society. While the market for human usable ARA is well established in North America and Europe, on account of more number of educated citizens and increased levels of healthcare awareness. The market is expected to witness a significant growth in Asia-Pacific region owing to the continuously growing end use applications such as medicines, animal care products, bodybuilding food supplements, and steroids. South America and Middle East Africa regions are expected to constantly grow with an average rate of around 3% per annum, over the forecast period.
The arachidonic acid is mostly used by the people who play sports on a regular basis, gym attendees, bodybuilders, weightlifters, and all other individuals who perform activities where a rapid burst of energy takes place. The athletes mainly require a sufficient amount of arachidonic acid level in their body, the lack of which can result in a decline in their performance, owing to which the industry is expected to witness an upswing over the next eight years. The increasing trend of gym goers and the increasing number of physical fitness centers seem to provide new avenues for the growth of this market.
The market is majorly categorized on the basis of the type of the product, such as nutritional food supplements & ingredients, nutritional oil & infant care products, diagnostic devices and cardiovascular health care products. All of these products are heavily used for a variety of purposes including the development of the central nervous system in infants & development of eyes, cardiac health care, genes and protein detection. The market also has a good presence in life science products, industrial chemicals, performance materials, nutritional products, cosmetics, pharmaceutical sector, and coatings.
Some of the key players in the market include Qingdao Fraken International Trading Co. Ltd, Cabio Biotech (Wuhan) Co., Ltd, Huatai Biopharm Inc., Baoding Faithful Industry Co.Ltd., DoubleNutra Biotech Co. Ltd, CR International (Hong Kong) Ltd, Bluebio (Yantai) Bio-Pharmaceutical Co. Ltd, Nutral and USA Inc.
Others include Nantong Qihai Nutraceuticals Co. Ltd. and Anderson Global Group LLC. These companies have expertise in making different types of products and have their own share of the market in the respective domains.
Avail customized purchase options to meet your research needs:
Get your queries resolved from an industry expert. Request for a free product review before report purchase.
Speak to the report author to design an exclusive study to serve your research needs.
A testimonial for service excellence represented in the form of BBB "A" Accreditation.
Your personal and confidential information is safe and secure.